Unveiling the Hidden Link: How Blood Lactate Levels Impact ALS Prognosis
Blood lactate levels may hold the key to unlocking a deeper understanding of ALS and its impact on patients' physical outcomes. A groundbreaking study conducted by researchers at The University of Queensland and Japan's Shiga University of Medical Science has revealed a surprising connection between blood lactate and ALS prognosis. This discovery could potentially revolutionize the way we approach treatment and care for individuals living with this devastating disease.
ALS, or Amyotrophic Lateral Sclerosis, is a form of motor neurone disease that gradually robs individuals of their ability to control voluntary muscle movement and breathe independently. The study, led by Dr. Ryutaro Nakamura of Shiga University, focused on the role of lactate as a potential biomarker for predicting physical outcomes in ALS patients.
Dr. Nakamura's research found that higher blood lactate levels in ALS patients were associated with better weight retention and improved prognosis. This finding challenges conventional beliefs and opens up new avenues for treatment and support.
The study, which included a Japanese patient cohort, was expanded through collaboration with Associate Professor Shyuan Ngo at the Australian Institute for Bioengineering and Nanotechnology and UQ School of Biomedical Sciences. Researchers monitored 146 ALS patients in Japan and Australia, confirming that those with low blood lactate levels experienced progressive weight loss after three months.
This discovery has significant implications for proactive nutritional support and the development of new treatments. Dr. Nakamura suggests that early and intensive nutritional support for patients with low blood lactate levels may improve outcomes and survival rates.
However, this research also raises questions and sparks debate. Some experts argue that the study's findings may not be universally applicable and could benefit from further validation. Others suggest that the correlation between blood lactate levels and ALS prognosis may be influenced by various factors, including race and environment.
What do you think? Do you agree with the study's findings, or do you have a different perspective? Share your thoughts and join the discussion!
Reference: Nakamura R, Steyn FJ, Kobashi S, et al. Blood lactate as a prognostic biomarker for survival and weight loss in amyotrophic lateral sclerosis: An exploratory–validation study. Ann Neurol. 2026. doi: 10.1002/ana.78184 (https://doi.org/10.1002/ana.78184)
This article has been republished from the following materials (https://news.uq.edu.au/2026-02-blood-lactate-levels-can-predict-physical-outcomes-als-patients) . Note: material may have been edited for length and content. For further information, please contact the cited source. Our press release publishing policy can be accessed here (https://www.technologynetworks.com/tn/editorial-policies#republishing) .
